Literature DB >> 3322706

[A double-blind study of T2 (tablets of polyglycosides of Tripterygium wilfodii hook) in the treatment of rheumatoid arthritis].

X L Tao, Y Dong, N Z Zhang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3322706

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


× No keyword cloud information.
  4 in total

Review 1.  A Systematic Review and Network Meta-Analysis about the Efficacy and Safety of Tripterygium wilfordii Hook F in Rheumatoid Arthritis.

Authors:  Hai-Long Wang; Qi Zhao; Wei Li; Hua-Chao Zhu; Liu Lv; Zhen-Hong Zhu; Xi-Xi Wang; Zheng-Zheng Yang; Yu-Cao Ma; Ming-Xuan Liu; Yi-Wen Wang; Hezheng Lai; Chun-Ping Liu; Yu-Zheng Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-10       Impact factor: 2.650

2.  Report of 12 cases of ankylosing spondylitis patients treated with Tripterygium wilfordii.

Authors:  Wei Ji; Juan Li; Yue Lin; Ya-Nan Song; Miaojia Zhang; Yao Ke; Yile Ren; Xiaohu Deng; Jianglin Zhang; Feng Huang; David Yu
Journal:  Clin Rheumatol       Date:  2010-06-19       Impact factor: 2.980

3.  A traditional Chinese medicine versus Western combination therapy in the treatment of rheumatoid arthritis: two-stage study protocol for a randomized controlled trial.

Authors:  Chi Zhang; Miao Jiang; Aiping Lu
Journal:  Trials       Date:  2011-06-04       Impact factor: 2.279

Review 4.  Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis.

Authors:  Hai-Long Wang; Quan Jiang; Xing-Hua Feng; Hua-Dong Zhang; Lin Ge; Cheng-Gui Luo; Xun Gong; Bo Li
Journal:  BMC Complement Altern Med       Date:  2016-07-13       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.